Sequans director reports warrant holdings in Form 3

Sequans Communications director Hubert de Pesquidoux filed an initial Form 3 detailing his derivative holdings in company securities.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Sequans Communications director Hubert de Pesquidoux filed an initial Form 3 detailing his derivative holdings in company securities. He reports several series of warrants on ordinary shares, including warrants over 360,000 ordinary shares at an exercise price of 0.1300 per share expiring on June 28, 2034, and another 360,000 underlying shares at 0.1500 per share expiring on June 30, 2035. Additional warrants cover smaller blocks of ordinary shares at exercise prices ranging from 0.5400 to 3.3100 with expirations between 2026 and 2033. A footnote explains that each American Depositary Share represents 100 ordinary shares.

Insider Trade Summary

10 transactions reported

Mixed 10 txns

Insider de Pesquidoux Hubert

Role Director

Type	Security	Shares	Price	Value
holding	Warrants	--	--	--
holding	Warrants	--	--	--
holding	Warrants	--	--	--
holding	Warrants	--	--	--
holding	Warrants	--	--	--
holding	Warrants	--	--	--
holding	Warrants	--	--	--
holding	Warrants	--	--	--
holding	Warrants	--	--	--
holding	Warrants	--	--	--

Holdings After Transaction: Warrants — 1,332,000 contracts (Direct)

Footnotes (1)

F1. Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Sequans Communications (SQNS) Form 3 for Hubert de Pesquidoux report?

The Form 3 reports Hubert de Pesquidoux’s initial beneficial ownership of Sequans derivative securities. It lists multiple warrant series on ordinary shares, detailing exercise prices, expiration dates, and underlying share amounts, establishing his starting warrant position as a company director.

How many Sequans (SQNS) ordinary shares are covered by Hubert de Pesquidoux’s lowest-priced warrants?

One warrant series covers 360,000 ordinary shares at an exercise price of 0.1300 per share. Another series covers 360,000 ordinary shares at 0.1500 per share, both directly owned, providing significant potential equity exposure if exercised.

What exercise prices and expirations are disclosed for Sequans (SQNS) director warrant holdings?

The filing shows warrants with exercise prices including 0.1300, 0.1500, 0.5400, 0.6500, 1.4900, 1.5100, 1.8600, 2.0400, 2.8900 and 3.3100. Expiration dates run from June 29, 2026 through June 30, 2035, reflecting long-dated derivative exposure.

Are there any buy or sell transactions in Sequans (SQNS) director Hubert de Pesquidoux’s Form 3?

No buy or sell transactions are reported; the entries are classified as holdings. The Form 3 simply records existing warrant positions and resulting ownership amounts, without showing any recent purchases, sales, exercises, or other changes in beneficial ownership.

How do Sequans (SQNS) ordinary shares relate to American Depositary Shares in this Form 3?

A footnote states the warrant exercise price is per ordinary share and that 100 ordinary shares are represented by each American Depositary Share. This clarifies how the disclosed underlying ordinary share amounts translate into ADS terms for investors tracking the U.S.-listed instrument.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/25/2026 - 09:15 AM

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

de Pesquidoux Hubert

(Last)

(First)

(Middle)

15-55 BOULEVARD CHARLES DE GAULLE

(Street)

COLOMBES

92700

(City)

(State)

(Zip)

FRANCE

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/25/2026

3. Issuer Name and Ticker or Trading Symbol
SEQUANS COMMUNICATIONS [ SQNS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Warrants	06/28/2025	06/28/2034	Ordinary Shares	360,000	$0.13⁽¹⁾	D
Warrants	06/30/2026	06/30/2035	Ordinary Shares	360,000	$0.15⁽¹⁾	D
Warrants	06/24/2023	06/24/2032	Ordinary Shares	140,000	$0.65⁽¹⁾	D
Warrants	07/01/2022	07/01/2029	Ordinary Shares	36,000	$2.89⁽¹⁾	D
Warrants	07/03/2020	07/03/2027	Ordinary Shares	30,000	$3.31⁽¹⁾	D
Warrants	06/29/2023	06/29/2030	Ordinary Shares	36,000	$1.51⁽¹⁾	D
Warrants	06/25/2022	06/25/2031	Ordinary Shares	140,000	$1.49⁽¹⁾	D
Warrants	06/29/2019	06/29/2026	Ordinary Shares	20,000	$1.86⁽¹⁾	D
Warrants	06/27/2024	06/27/2033	Ordinary Shares	180,000	$0.54⁽¹⁾	D
Warrants	07/02/2021	07/02/2028	Ordinary Shares	30,000	$2.04⁽¹⁾	D

Explanation of Responses:

1. Warrant exercise price is the price per ordinary share; there are 100 ordinary shares represented by each American Depositary Share

Remarks:

	/s/Muriel Murat, Attorney-in-Fact for Hubert de Pesquidoux	03/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR